Collegium Pharmaceutical ... (COLL)
NASDAQ: COLL
· Real-Time Price · USD
37.71
0.55 (1.48%)
At close: Aug 15, 2025, 3:59 PM
37.74
0.08%
After-hours: Aug 15, 2025, 04:34 PM EDT
Collegium Pharmaceutical Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 98.16 | 18.33 | 33.38 | 13.49 | 11.34 | 7.78 | 9.14 | 14.30 | -11.81 | -27.06 | 298.48 | -29.02 | -13.05 | -6.36 | 21.71 | 2.86 | 13.22 |
PEG Ratio | -1.23 | 1.01 | -0.74 | -0.45 | -0.86 | 0.12 | 0.15 | -0.08 | -0.08 | 0.02 | -2.74 | 0.47 | 0.28 | 0.02 | -0.24 | 0.01 | 0.11 |
PS Ratio | 5.34 | 5.05 | 7.82 | 7.28 | 8.67 | 6.64 | 5.52 | 5.49 | 5.69 | 6.01 | 4.30 | 4.88 | 8.15 | 23.29 | 8.86 | 10.06 | 9.44 |
PB Ratio | 4.05 | 4.02 | 5.32 | 4.88 | 5.66 | 5.09 | 4.22 | 3.71 | 4.58 | 4.00 | 2.77 | 3.05 | 3.48 | 3.14 | 2.78 | 3.30 | 4.87 |
P/FCF Ratio | 17.38 | 10.93 | -134.86 | 15.76 | 20.48 | 13.59 | 10.20 | 7.47 | 29.94 | 11.92 | 12.79 | 15.07 | -26.84 | 17.86 | 41.16 | 28.97 | 41.13 |
P/OCF Ratio | 17.13 | 10.86 | -138.52 | 15.70 | 20.29 | 13.56 | 10.19 | 7.46 | 29.75 | 11.75 | 12.76 | 14.89 | -26.95 | 17.60 | 40.50 | 28.26 | 40.27 |
OCF/S Ratio | 0.31 | 0.47 | -0.06 | 0.46 | 0.43 | 0.49 | 0.54 | 0.74 | 0.19 | 0.51 | 0.34 | 0.33 | -0.3 | 1.32 | 0.22 | 0.36 | 0.23 |
Debt / Equity Ratio | 3.60 | 3.75 | 3.73 | 2.58 | 2.84 | 3.45 | 4.02 | 3.80 | 4.49 | 4.48 | 3.71 | 3.82 | 3.97 | 1.52 | 1.08 | 1.12 | 1.73 |
Quick Ratio | 1.01 | 0.88 | 0.88 | 1.04 | 1.14 | 1.10 | 1.08 | 1.18 | 1.13 | 1.38 | 0.82 | 0.80 | 0.76 | 1.29 | 1.29 | 1.32 | 1.22 |
Current Ratio | 1.08 | 0.95 | 0.97 | 1.11 | 1.21 | 1.17 | 1.16 | 1.24 | 1.21 | 1.55 | 0.98 | 0.99 | 0.97 | 1.37 | 1.35 | 1.40 | 1.29 |
Asset Turnover | 0.11 | 0.11 | 0.10 | 0.14 | 0.13 | 0.13 | 0.12 | 0.11 | 0.12 | 0.11 | 0.11 | 0.10 | 0.07 | 0.04 | 0.11 | 0.12 | 0.14 |
Interest Coverage | 1.04 | 1.68 | 1.89 | 3.05 | 2.85 | 3.20 | 2.17 | 1.63 | 1.15 | -1.47 | 1.07 | 0.63 | -1.72 | -7.17 | 2.77 | 3.03 | 3.70 |
Return on Equity | 0.01 | 0.05 | 0.04 | 0.09 | 0.12 | 0.16 | 0.12 | 0.06 | -0.1 | -0.04 | n/a | -0.03 | -0.07 | -0.12 | 0.03 | 0.29 | 0.09 |
Return on Assets | n/a | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 | -0.01 | -0.01 | n/a | n/a | -0.01 | -0.04 | 0.01 | 0.10 | 0.02 |
Return on Invested Capital | 0.01 | 0.02 | 0.02 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.02 | -0.03 | 0.01 | 0.01 | -0.01 | -0.04 | 0.02 | 0.20 | 0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.55 | 0.54 | 0.61 | 0.63 | 0.63 | 0.63 | 0.59 | 0.54 | 0.53 | 0.38 | 0.46 | 0.42 | 0.58 | -0.05 | 0.58 | 0.61 | 0.63 |
Net Profit Margin | 0.01 | 0.07 | 0.06 | 0.13 | 0.19 | 0.21 | 0.15 | 0.10 | -0.12 | -0.06 | 0.00 | -0.04 | -0.16 | -0.91 | 0.10 | 0.88 | 0.18 |
Pretax Profit Margin | 0.02 | 0.09 | 0.10 | 0.20 | 0.25 | 0.31 | 0.21 | 0.13 | -0.12 | -0.06 | 0.01 | -0.05 | -0.19 | -1.42 | 0.11 | 0.13 | 0.18 |
Operating Profit Margin | 0.12 | 0.21 | 0.22 | 0.33 | 0.34 | 0.41 | 0.33 | 0.26 | 0.17 | -0.23 | 0.16 | 0.09 | -0.12 | -1.25 | 0.18 | 0.20 | 0.24 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.45 | 0.53 | 0.48 | 0.55 | 0.62 | 0.68 | 0.63 | 0.57 | 0.29 | 0.39 | 0.46 | 0.40 | 0.12 | -0.62 | 0.40 | 0.41 | 0.44 |